Corporate

  • September 24, 2026

    Texas Utility Commission Looks To Quash Coal Subpoena

    The Public Utility Commission of Texas is pushing back against a subpoena issued by BlackRock in a suit from Republican state attorneys general accusing asset managers of driving up coal prices by pressuring producers to lower their output to meet emission reduction goals.

  • September 24, 2026

    Congressional Probes Raise Legal, 'Reputational' Risks

    An array of companies and executives may face investigations over their dealings with the Trump administration if Democrats take control of Congress, raising the possibility that some may refuse to comply. But experts say holding out hope for a mass pardon or expecting the Justice Department not to pursue contempt charges is a risky bet.

  • September 24, 2026

    Mining Co. Investor Says Sprott Got Control Without Premium

    A Hycroft Mining shareholder has alleged in Delaware Chancery Court the company's board handed control of the business to Canadian billionaire Eric Sprott through a series of stock issuances without demanding a control premium, even as it was sitting on favorable information about a major discovery of silver.

  • September 24, 2026

    Troutman Adds Finn Dixon Investment Management Leader

    Troutman Pepper Locke LLP has grown its Connecticut outpost with the addition of Finn Dixon & Herling LLP's former investment management practice leader.

  • September 24, 2026

    Alston & Bird Adds 2 Ex-Loeb & Loeb Commercial Litigators

    Alston & Bird LLP has added two commercial litigators in California previously with Loeb & Loeb LLP who specialize in business disputes, the firm announced Thursday.

  • September 23, 2026

    Huawei Used Joint Venture Talks For IP Heist, Jury Hears

    Jurors in the corporate criminal trial of Huawei saw evidence Wednesday suggesting proprietary information for Quintel Tech. Ltd.'s technology for improving cell phone reception was used in a patent application by a Huawei engineer amid joint venture talks, as prosecutors continued to assert the Chinese telecommunications giant made trade secret theft one of its central business strategies.

  • September 24, 2026

    Litigation Spending To Keep Climbing While Biz Risks Mount

    Big companies will increase their litigation budgets yet again next year, as navigating legal risk is now an essential element of achieving strategic business goals, according to a new report.

  • September 23, 2026

    DOJ Eyes Per Se Rule In Fragrance Antitrust Suit

    The U.S. Department of Justice told a New Jersey federal judge Tuesday that it plans to weigh in on fragrance-makers' bid to dismiss purchasers' price-fixing claims, saying the motion raises "significant questions" about a Third Circuit antitrust ruling that the court revised after the department challenged its wording.

  • September 23, 2026

    Nestle Asks Justices To Review 'Sustainable' Cocoa Classes

    Nestle asked the U.S. Supreme Court to review a divided Ninth Circuit decision upholding class certification of millions of consumers who bought chocolate labeled "sustainably sourced" in a lawsuit claiming the chocolate is produced through child labor and deforestation.

  • September 23, 2026

    NY Times Board Failed To Probe Anti-Israel Bias, Fla. Says

    The New York Times Co.'s directors failed to address anti-Israel bias in the paper's coverage despite concerns about a freelancer who praised Adolf Hitler and repeated complaints from a newsroom whistleblower, a Florida state agency and a conservative think tank told a New York state court Wednesday.

  • September 23, 2026

    SEC Issues Wave Of Industry Bars Over Past Violations

    As its fiscal year draws to a close this month, the U.S. Securities and Exchange Commission has issued a bevy of opinions barring defendants from the securities industry, following a D.C. federal judge's ruling earlier this year that a U.S. Supreme Court decision curtailing the agency's use of its administrative courts doesn't preclude the SEC's ability to pursue industry bans.

  • September 23, 2026

    JPMorgan Can't Scrap $4.25M Award Over Super Bowl Food

    A California federal judge has mostly denied JPMorgan's bid to vacate a $4.25 million arbitration award for a former wealth manager who was fired for expensing $642.40 worth of food for a Super Bowl party, finding vacatur isn't warranted, even if JPMorgan raised "serious challenges."

  • September 23, 2026

    Microsoft Heads Face Derivative Action Over Inflection AI Deal

    Three Microsoft Corp. investors filed a shareholder derivative suit in Washington state court Monday over claims the company's leaders wrongfully approved a March 2024 licensing agreement with Inflection AI Inc. aimed at bailing out Microsoft co-founder Bill Gates and entrepreneur Reid Hoffman after their investments in the startup soured.

  • September 23, 2026

    Blue Shield Still Facing Therapy 'Ghost Network' Suit

    A California federal judge ruled Wednesday that Blue Shield of California must face the majority of claims brought in subscribers' proposed class action alleging the insurer maintained a "ghost network" of mental-health providers that didn't exist or accept new patients, saying the suit adequately claims contract terms were not met.

  • September 23, 2026

    Publix Sued Over Woman's Death From Eating Blueberries

    A Florida man whose wife died after allegedly consuming contaminated frozen blueberries has sued Publix Super Markets Inc. and a food distributor, alleging the companies sold a dangerous food product that caused a fatal infection.

  • September 23, 2026

    Honeywell Aerospace Hit With Suit Over $2M DOJ Settlement

    Honeywell Aerospace is facing an investor suit alleging it failed to disclose a federal investigation that led to a $2 million settlement with the U.S. Department of Justice and that a small set of suppliers had a "disproportionate impact" on the aerospace and defense company's revenue.

  • September 23, 2026

    Exelon Investors' $40M Deal In Bribery Case Wins Final OK

    An Illinois federal judge on Tuesday granted final approval to a $40 million settlement resolving Exelon shareholders' claims against company leaders connected to the Commonwealth Edison bribery scandal, over the objections of some investors who argued that most benefits were already paid, previously implemented, or too small to justify releasing valuable claims.

  • September 23, 2026

    DOJ Partially Backs Apple In Epic High Court Contempt Case

    The U.S. Department of Justice told the U.S. Supreme Court in an amicus brief that the Ninth Circuit wrongly faulted Apple for charging a 27% commission on transactions linked out from apps, but it backed other parts of the California federal court's contempt order won by Epic Games.

  • September 23, 2026

    Vein Tech Maker Escapes Suit Over DOJ Kickback Probe

    A New York federal judge has tossed, for now, a proposed investor class action alleging that vein disease device maker Inari Medical Inc.'s share price fell after it disclosed an investigation into its compliance with federal anti-kickback laws, finding the suit does not plausibly show Inari was paying healthcare providers unlawful kickbacks, among other things.

  • September 23, 2026

    Fla. Court Says Tesla Shouldn't Transfer Fatal Crash Suit

    A Florida state judge on Wednesday issued a report recommending denial of Tesla Inc.'s bid to transfer a fatal crash lawsuit from Broward County to Miami-Dade County, saying it's too late to move the case after nearly five years of litigation. 

  • September 23, 2026

    NJ Bias Case Judge Won't Nix Hospital's NDA Rule Yet

    A New Jersey state judge said it was too early to strike down a hospital's nondisclosure agreement provision for internal investigations in a former director's suit alleging she was the target of a retaliatory investigation.

  • September 23, 2026

    Vividion Investor Wants IP Suit Over $2B Bayer Deal Revived

    CHP III LP urged the Delaware Supreme Court on Wednesday to revive its suit over allegedly diverted intellectual property in Vividion Therapeutics Inc.'s $2 billion sale to Bayer Corp., while the defendants argued the investor is trying to turn a corporate injury into a direct stockholder claim that did not survive the merger.

  • September 23, 2026

    Del. Justices Weigh If Corporations Can Vote In Beach Town

    The ACLU of Delaware urged the state's high court Wednesday to revive its challenge to Fenwick Island's practice of allowing property-owning corporations and other artificial entities to vote in municipal elections, arguing the system unlawfully dilutes residents' votes.

  • September 23, 2026

    OpenAI Looks To End SpaceXAI's Apple Deal Antitrust Case

    OpenAI is urging a Texas federal court to end an antitrust case from Elon Musk's SpaceXAI over a deal integrating ChatGPT into Apple devices, saying the pact is not exclusive and does not block competition from rival chatbots.

  • September 23, 2026

    NY Judge Dismisses States' DOGE Treasury Data Access Suit

    A New York federal judge Wednesday tossed several states' lawsuit that challenged Department of Government Efficiency staff access to U.S. Department of the Treasury data, saying DOGE's dissolution rendered the states' access claims moot and that they failed to allege that any federal funding due to them was ultimately canceled.

Expert Analysis

  • How Trucking Cos. Can Tackle Risk From New DOJ Task Force

    Author Photo

    Trucking companies should audit their drivers’ credentials and address risk areas lest they attract the attention of the new Justice Department-led task force against the fraudulent licensing of immigrants as commercial truckers, which is turning former questions of administrative or regulatory noncompliance into matters for federal prosecution, say attorneys at RJO.

  • 2 Cases Shed Light On Invoking The 5th Before Congress

    Author Photo

    Given the anticipated increase in congressional investigations following the midterm elections, those who anticipate being in Congress' spotlight can draw valuable Fifth Amendment lessons from the ongoing case involving Dr. Anthony Fauci's testimony and the D.C. Circuit’s recent ruling in de la Torre v. Cassidy, say attorneys at King & Spalding.

  • Intersecting Investigation Risks Loom In Next Congress

    Author Photo

    Taken together, two July D.C. Circuit decisions and a recent U.S. Department of Justice opinion on executive privilege may affect the procedural defenses and privilege protections available to targets of oversight in the upcoming Congress, and companies should begin preparing now, say attorneys at WilmerHale.

  • FTC Focus: A Shift In The Pricing Disclosure Terrain

    Author Photo

    Recent state and Federal Trade Commission developments spotlight materially different ways in which personalized pricing might be addressed, which could result in an increasingly fragmented regulatory landscape in which businesses face differing disclosure obligations and substantive restrictions depending upon the jurisdiction, say attorneys at Proskauer.

  • Del. Ruling Emphasizes High Bar To Pleading A Control Group

    Author Photo

    The Delaware Court of Chancery's recent decision in Le Clair v. KnowBe4 illustrates the high burden to which courts hold plaintiffs trying to establish a control group, as well as the continued power of an informed stockholder vote, say attorneys at Sidley.

  • Attorneys Using AI May Have Ethical Duty To Redact Docs

    Author Photo

    The trajectory of legal ethics guidance in recent years strongly suggests that as redaction technology becomes more accessible, the failure to use it when uploading highly confidential materials into artificial intelligence tools will become increasingly difficult to defend as reasonable, say attorneys at Lewis Brisbois.

  • Compliance Lessons From Agriculture Co. Mexican Bribe DPA

    Author Photo

    Agricultural company Scoular’s recently announced deferred prosecution agreement over alleged Foreign Corrupt Practices Act violations at the U.S.-Mexico border reinforces the U.S. Department of Justice’s focus on cartels, and companies must accordingly ensure they address risks associated with the use of customs brokers, says Adam Safwat at Foley Hoag.

  • 5 Practice Tips After DOJ's Healthcare Fraud Declination

    Author Photo

    In light of the U.S. Department of Justice's decision to not prosecute Campus Eye Management under the agency's new corporate enforcement and voluntary self-disclosure policy, healthcare companies should keep several considerations in mind when weighing their risk and self-disclosure strategy, including the distinctions between reporting to the DOJ versus other government agencies, say attorneys at Haynes Boone.

  • Assessing The Early Days Of Woodcock's SEC Tenure

    Author Photo

    Since David Woodcock took over the U.S. Securities and Exchange Commission's Division of Enforcement four months ago, the division has pursued a scaled-back caseload centered on fraud and manipulative conduct, largely following the enforcement outlook that emerged under SEC Chairman Paul Atkins, say attorneys at Akerman.

  • Series

    Juggling And Unicycling Make Me A Better Lawyer

    Author Photo

    Because I juggle (sometimes with fire) and ride the unicycle, friends and family used to joke that I should join the circus, but I pursued the practice of law instead and learned that my hobbies benefit my profession in several important ways, says Morgan Eddy at Smith Currie.

  • DOJ Executive Privilege Opinion Portends 3rd-Party Dilemmas

    Author Photo

    The recent opinion from the U.S. Department of Justice’s Office of Legal Counsel concluding that executive privilege can shield the president's communications with private advisers may lead to interbranch disputes, and companies must come up with a response plan now before they’re caught in the middle, say attorneys at Gibson Dunn.

  • Planning For The Impact Of FinCEN's CTA Rollback

    Author Photo

    The Financial Crimes Enforcement Network's recent rollback of Corporate Transparency Act reporting obligations should reduce compliance costs, but its plans to revisit customer due diligence rules should prompt companies and financial institutions to reassess state beneficial ownership programs, say attorneys at Sidley.

  • Justices' Hikma Reasoning May Extend Well Beyond Pharma

    Author Photo

    The active steps framework announced by the U.S. Supreme Court in its Hikma v. Amarin decision, finding that Amarin failed to plausibly allege inducement of infringement, has the potential to reshape how courts evaluate inducement claims across patent, copyright and other doctrines, say attorneys at BCLP.

  • Teva MDL Loss Shows DPAs Can Return To Haunt Civil Suits

    Author Photo

    Teva’s recent partial summary judgment loss in antitrust multidistrict litigation reinforces the importance of carefully scrutinizing any statement of facts a company admits to in a deferred prosecution agreement, and illustrates the potential costs of resolving a criminal investigation this way, say attorneys at Sheppard.

  • 11th Circ. FCA Qui Tam Revival Queues Up Next Challenges

    Author Photo

    Though the Eleventh Circuit on Sept. 1 upheld the constitutionality of the False Claims Act's qui tam provision, it will probably face continued litigation since the appellate court declined to rule on other constitutional challenges and the decision will likely be petitioned to the U.S. Supreme Court, say attorneys at Sheppard.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.